DNTH
Dianthus Therapeutics
$103.28
−$3.76 (−3.51%)Sep 10, 2026
Key metrics
The numbers that frame DNTH today
- Market cap
- $5.78B
- P/E (TTM)
- -30.0
- EV / FCF
- -36.4
- Gross margin
- 100%
- EV / Sales
- 2,976.7
- ROIC
- -29.6%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $32.22
- 52wk High
- $117.88
Growth
Revenue and earnings trend for DNTH
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about DNTH
Is Dianthus Therapeutics a good buy?
Hold. Dianthus Therapeutics has excellent momentum, but poor quality makes the setup mixed. Growth looks excellent, which supports the long-term business case, but quality and momentum do not clear the bar together. We think Dianthus Therapeutics is selling at a high price.
What is the market capitalization of DNTH?
Dianthus Therapeutics's market capitalization is $5.78B.
What is the P/E ratio for DNTH stock?
Dianthus Therapeutics's current P/E ratio is -30.
What is the 52-week high for DNTH stock?
The 52-week high for Dianthus Therapeutics is $117.88. The current close of $103.28 is 12.4% below that high.
What is the 52-week low for DNTH stock?
The 52-week low for Dianthus Therapeutics is $32.22. The current close of $103.28 is 220.5% above that low.
Does DNTH stock pay dividends?
Dianthus Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for DNTH?
Dianthus Therapeutics's Debt / Equity ratio is 0.